Therefore, reduction in SMN protein levels by ~65% (Zpr1Hb9MNΔ) and ~50% (Zpr1ChATMNΔ) suggest development of severe to moderate SMA-like disease in Zpr1 mutant mice. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.